^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NM21-1480

    i
    Other names: NM21-1480, ND021, PD-L1/4-1BB/HSA trispecific scDb-scFv , CS2006
    Associations
    News
    Trials
    Company:
    CStone Pharma, Numab
    Drug class:
    PD-L1 inhibitor, CD137 agonist
    Related drugs:
    Associations
    News
    Trials